Heart Failure Readmission ROI

Heart Failure Readmission ROI

animation
healthcare
medication
Try Increase Improved adherence (%) while keeping baseline adherence unchanged. Then press Calculate readmission ROI.
Observe Watch prevented readmissions and ROI year 1 as Improved adherence (%) changes.
Explain Describe how Baseline adherence (%) affects the modeled reduction in nonadherence after you press Calculate readmission ROI.

Technical boundaries. The formula applies relative reduction in nonadherence directly to assumed adherence-related readmissions. This effect requires independent validation; integration and monitoring costs are fixed, and payer reimbursement is separate.

Heart Failure Readmission ROI

Scenario: A health system deploys smart pill bottles for heart failure patients to improve medication adherence and reduce hospital readmissions.

Given:

  • Modeled 30-day readmission rate: 25%, close to the 24.5% CMS reported for Medicare heart-failure discharges in 2009; validate against the target cohort. (CMS)
  • Cost per readmission: $13,000 (CMS penalty + treatment)
  • Hypothetical model input: attribute 40% of readmissions to medication nonadherence, pending a defined readmission study.
  • Smart bottle cost: $45 per device + $3/month connectivity
  • Assumed intervention effect: adherence rises from 65% to 88%; this is not a demonstrated smart-bottle result.
  • Program duration: 12 months

Steps:

  1. Calculate baseline readmissions attributable to non-adherence:
    • Among 1,000 index discharges, the assumed 25% 30-day rate yields 250 readmissions within 30 days.
    • Under the assumed 40% attribution, 100 is the product of the assumed 250 readmissions and assumed attribution; it is not an observed count.
    • Baseline adherence-related cost: 100 × $13,000 = $1,300,000
  2. Calculate improved readmissions with smart bottles:
    • Adherence rises from 65% to 88% (23 percentage points; 35.4% relative increase); nonadherence falls from 35% to 12% (65.7% relative reduction). A readmission effect must be independently estimated.
    • Prevented non-adherence readmissions: 100 × 0.35 = 35 readmissions avoided
    • Remaining adherence-related readmissions: 100 - 35 = 65 readmissions
    • New adherence-related cost: 65 × $13,000 = $845,000
  3. Calculate program cost:
    • Device cost: 1,000 × $45 = $45,000 (one-time)
    • Connectivity: 1,000 × $3 × 12 = $36,000 (annual)
    • Integration labor (FHIR API, EHR): $25,000 (one-time)
    • Clinical monitoring staff: $80,000/year (nurse reviewing adherence data)
    • Total Year 1 cost: $186,000
  4. Calculate net savings:
    • Prevented readmission savings: $1,300,000 - $845,000 = $455,000
    • Net savings Year 1: $455,000 - $186,000 = $269,000
    • Modeled first-year ROI: $269,000/$186,000 ≈ 145%, conditional on validating the assumed avoided admissions.
  5. Calculate Medicare reimbursement potential:
    • RPM code 99454 (device supply): 1,000 × $62/month × 12 = $744,000
    • RPM code 99457 (first 20 min): 1,000 × $51/month × 12 = $612,000
    • Total reimbursable: $1,356,000 (offsets costs and creates revenue stream)

Result: Under these assumptions, gross avoided admission costs are about 2.45 times program cost and net modeled savings about 1.45 times cost; payer reimbursement is a separate uncertain line item. Any modeled benefit depends on validating avoided admissions and separately accounting for treatment costs, CMS payment adjustments, device purchase, connectivity, integration and staff.

Key insight: Healthcare IoT economics depend on separately modeled treatment costs, payer adjustments, device and connectivity costs, integration, and staff; do not equate an avoided admission with an avoided CMS penalty.

Back to the chapter